Clarus Therapeutics Inc.

NASDAQ: CRXT · Real-Time Price · USD
0.05
-0.02 (-27.54%)
At close: Sep 06, 2022, 7:59 PM

Clarus Therapeutics Revenue

Clarus Therapeutics reported an annual revenue of $13.96M, reflecting a undefined% growth. For the quarter ending June 30, 2022, Clarus Therapeutics generated $4.05M in revenue.
Revenue (ttm)
-
Revenue Growth
undefined%
Price / Sales Ratio
undefined
Revenue / Employee
-
Employees
undefined
Market Cap
0

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.